TGM2 and central nervous system cancer: IR of the brain microenvironment, beside inducing senescence, also supports glioma stemness and survival via TGM2 (transglutaminase 2) secretion by astrocytes [248], and inhibition of PAF (PCNA-associated factor) turns those cells more sensitive to IR [249].